American Clinical Laboratory Association - Citizen Petition
This Other document was issued by the Food and Drug Administration (FDA)
For related information, Open Docket Folder
See attached file(s)
No documents available.
Exhibit 3 Turna Ray FDA Shelves IVDMIA Final Guidelines in Order to Focus on Overall LDT Regulation
Exhibit 5 Medical Device Amendments of 1976 Conference Report 94th Congress House of Representatives Report 94 1090
Exhibit 6 Medical Device Amendments of 1976 Report 94th Congress House of Representatives Report 94 853
Exhibit 7 Medical Device Amendments Report 1975 94th Congress Senate Report 94 33
Exhibit 9 Food Drugs and Cosmetics Hearing before Subcommittee of the Committee on Interstate and Foreign Commerce 74th Congress
Exhibit 11 House of Representatives Clinical Laboratory Improvement Amendments of 1988
Exhibit 12 Deadly Mistakes Are Laboratory Results Reliable Hearings before Subcommittee on Regulation and Business Opportunities...
Exhibit 13 Medical Testing Improvement Act of 1988 100th Congress Senate Report 100 561
Exhibit 15 Turna Ray Qiagen Enters Companion Dx Market With Approval of KRAS Test Kit for Erbitux
Exhibit 16 Nowak and Kaul The Role of Community Molecular Diagnostics Laboratories in the H1N1 Pandemic
| || |
Show More Details
Date Posted: Jun 17, 2013
Country: United States
Category: Private Industry - C0003
On Behalf of the Combination Products Coalition ("CPC") and the CPC Personalized Medicine Working Group, please find attached our comments on the American...
Quest Diagnostics Incorporated submits the attached document in support of the Citizen Petition filed by the American Clinical Laboratory Association regarding...
Dear Sir or Madam: I wish to submit comments in support of the American Clinical Laboratory Association’s (ACLA) citizen petition (Docket No. FDA-2013-P-0667...
This document is contained in
Related RINs: None
* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.